1 |
Shin, A., Cho, E. R., Kim, J., Sung, J., Park, K. W., Lim, M. K., et al. (2009). Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea. Cancer Epidemiology, Biomarkers & Prevention, 18(6), 1894-1898. http://dx.doi.org/10.1158/1055-9965
DOI
|
2 |
Shin, H. R. (2006). Epidemiology of hepatitis C virus in Korea. Intervirology, 49(1-2), 18-22. http://dx.doi.org/10.1159/000087258
DOI
|
3 |
Shin, H. R., Kim, J. Y., Song, J. B., Suh, B. S., Kim, J. M., Lee, B. O., et al. (1997). Seroepidemiologic study of hepatitis B virus(HBV) and hepatitis C(HCV) infection among Koreans in rural area, Korea. Journal of Preventive Medicine and Public Health, 30(1), 17-29.
|
4 |
Stanaway, J. D., Flaxman, A. D., Naghavi, M., Fitzmaurice, C., Vos, T., Abubakar, I., et al. (2016). The global burden of viral hepatitis from 1990 to 2013; findings from the Gobal Burden of Disease Study 2013. Lancet, 388(10049), 1081-1088. http://dx.doi.org/10.1016/S0140-6736(16)30579-7
DOI
|
5 |
Suh, D. H., & Jeong, S. H. (2006). Current status of hepatitis C virus infection in Korea. Intervirology, 49(1-2), 70-75. http://dx.doi. org/10.1159/000087266
DOI
|
6 |
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. A Cancer Journal for Clinicians, 65(2), 87-108. http://dx.doi.org/10.3322/caac.21262
DOI
|
7 |
World Health Organization. (2004). Global burden of disease (GBD) for hepatitis C. Journal of Clinical Pharmacology, 44(1), 20-29. http://dx.doi.org/10.1177/0091270003258669
DOI
|
8 |
World Health Organization. (2016). Media Centre: Fact sheets. Retrieved July 28, 2016, from http://www.who.int/mediacentre/factsheets/fs164/en/
|
9 |
Averhoff, F. M., Glass, N., & Holtzman, D. (2012). Global burden of hepatitis C: considerations for healthcare provider in the United States. Clinical Infectious Disease, 55(Suppl 1), S10-15. http://dx.doi.org/10.1093/cid/cis361
DOI
|
10 |
Dalgard, O., Jeansson, S., Skaug, K., Raknerud, N., & Bell, H. (2003). Hepatitis C in the general adult population of Oslo; prevalence and clinical spectrum. Scandinavian Journal of Gastroenterology, 38(8), 864-870.
DOI
|
11 |
Korea Centers for Disease Control and Prevention. (2013). Survey on prevalence and risk factors in high risk area of hepatitis C(2013E2400100), Osong: Author.
|
12 |
Hastert, T. A., Beresford, S. A., Sheppard, L., & White, E. (2015). Disparities in cancer incidence and mortality by area-level socioeconomic status: a multilevel analysis. Journal of Epidemiology and Community Health, 69(2), 168-176. http://dx.doi.org/10.1136/jech-2014-204417
DOI
|
13 |
Institute of Medicine. (2010). Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C, Washington, DC: The National Academies Press.
|
14 |
Jeong, S. H. (2017). Current status of hepatitis C virus infection and countermeasures. Public Health Weekly Report, KCDC, 10(9), 212-219.
|
15 |
Kim, C. Y., Lee, H. S., & Han, C. J. (1993). Relative Etiologic role of hepatitis B virus and hepatitis C virus in chronic liver diseases and hepatocellular carcinoma among age-specific groups in Korea: the possible presence of Non-B, Non-C agents. The Seoul Journal of Medicine, 34(1), 27-33.
|
16 |
Kim, I. H., Jeong, S. H., Cho, Y. K., Lee, J. H., Jin, Y. J., Lee, D., et al. (2013). A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver International, 33(4), 589-594. http://dx.doi.org/10.1111/liv.12108
DOI
|
17 |
Kozakiewicz, K., Podolecka, E., Kwasniewska, M., Drygas, W., Pajak, A., & Tendera, M. (2016). Association between socioeconomic status and cardiovascular risk. Kardiologia Polska, 74(2), 179-184. http://dx.doi.org/10.5603/KP.a2015.0139
DOI
|
18 |
Lavanchy, D. (2011). Evolving epidemiology of hepatitis C virus. Clinical Microbiology and Infection, 17(2), 107-115. http://dx.doi.org/10.1111/j.1469-0691.2010.03432.x
DOI
|
19 |
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. The New England Journal of Medicine, 341(8), 556-562.
DOI
|
20 |
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine, 144(10), 705-714.
DOI
|
21 |
Lee, K. I., Park, K. S., Seo, H. J., Kim, T. Y., Kim, E. S., Jang, B.K., et al. (2011). Shifting in seroprevalence of HBsAg and Anti-HCV during recent 10 years in adults resident in Daegu and Gyeongbuk province. The Korean Journal of Gastroenterology, 58(2), 82-87.
DOI
|
22 |
Qureshi, H., Bile, K. M., Jooma, R., Alam, S. E., & Afridi, H. U. (2010). Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. Eastern Mediterranean Health Journal, 16(Suppl), S15-23.
DOI
|
23 |
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet, 380(9859), 2095-2128. http://dx.doi.org/10.1016/S0140-6736(12)61728-0
DOI
|
24 |
Madhava, V., Burgess, C., & Drucker, E. (2002). Epidemiology of chronic hepaitis C virus infection in sub-Saharan Africa. The Lancet. Infectious Disease, 2(5), 293-302.
|
25 |
Meffre, C., Le Strat, Y., Delarocque-Astagneau, E., Dubois, F., Antona, D., Lemasson, J. M., et al. (2010). Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. Journal of Medical Virology, 82(4), 546-555. http://dx.doi.org/10.1002/jmv.21734
DOI
|
26 |
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013). Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology, 57(4), 1333-1342. http://dx.doi.org/10.1002/hep.26141
DOI
|
27 |
Omland, L. H., Osler, M., Jepsen, P., Krarup, H., Weis, N., Christensen, P. B., et al. (2013). Socioeconomic status in HCV infected patients-risk and prognosis. Clinical Epidemiology, 5, 163-172. http://dx.doi.org/10.214/CLEP.S43926
DOI
|
28 |
Shepard, C. W., Finelli, L., & Alter, M. (2005). Global epidemiology of hepatitis C virus infection. The Lancet. Infectious Disease, 5(9), 558-567. http://dx.doi.org/10.1016/S1473-3099(05)70216-4
DOI
|